Abstract
Hidradenitis suppurativa (HS) affects different patient populations that require unique considerations in their management. However, no HS guidelines for these populations exist.BACKGROUNDHidradenitis suppurativa (HS) affects different patient populations that require unique considerations in their management. However, no HS guidelines for these populations exist.To provide evidence-based consensus recommendations for patients with HS in seven special patient populations: i) pregnancy, ii) breastfeeding, iii) pediatrics, iv) malignancy, v) tuberculosis infection, vi) hepatitis B or C infection, and vii) HIV disease.OBJECTIVETo provide evidence-based consensus recommendations for patients with HS in seven special patient populations: i) pregnancy, ii) breastfeeding, iii) pediatrics, iv) malignancy, v) tuberculosis infection, vi) hepatitis B or C infection, and vii) HIV disease.Recommendations were developed using the Grading of Recommendations Assessment, Development and Evaluation system to ascertain level of evidence and selected through a modified Delphi consensus process.METHODSRecommendations were developed using the Grading of Recommendations Assessment, Development and Evaluation system to ascertain level of evidence and selected through a modified Delphi consensus process.119 expert consensus statements are provided for the management of patients with HS across these seven special patient populations.RESULTS119 expert consensus statements are provided for the management of patients with HS across these seven special patient populations.